In this issue:
StratifyJCV vs. Immunowell JCV assays
A proposed standardised definition of PIRA
Seizures & reduced cognitive function in MS
Brain atrophy with cladribine in RRMS
Intrathecal methotrexate for progressive MS
TONiC: axonal length & MS body part involvement
Sun exposure & relapse risk in paediatric-onset MS
DMT & disability worsening in PPMS by disease trajectory
Real-world infection rates with ocrelizumab
TITAN: work function & quality of life with natalizumab in RRMS
Please login below to download this issue (PDF)